Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

• Status: Completed
• Trial end date: 2009-12-01

Summary

The aim of this study is to compare the efficacy and safety of Low molecular weight heparin (LMWH) plus low dose aspirin (LDA) with unfractionated heparin(UFH) plus LDA in women with recurrent pregnancy loss associated with antiphospholipid syndrome (APS).

• Phase: Phase 2

Details

• Lead Sponsor: Cairo University
• Collaborator: Ahmed Elgazzar Hospital
• Treatments: Aspirin; Calcium; Calcium heparin; Calcium, Dietary; Dalteparin; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight